Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
48
TFX Quote, Financials, Valuation and Earnings
Last price:
$177.05
Seasonality move
:
8.84%
Day range:
$176.38 - $178.91
52-week range:
$171.69 - $256.85
Dividend yield:
0.77%
P/E ratio:
35.24x
P/S ratio:
2.77x
P/B ratio:
1.84x
Volume:
114.8K
Avg. volume:
468.9K
1-year change:
-29.36%
Market cap:
$8.2B
Revenue:
$3B
EPS (TTM):
$5.03
Analysts' Opinion
-
Consensus RatingTeleflex has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 9 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $238.68, Teleflex has an estimated upside of 34.65% from its current price of $177.26.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $200.00 representing 100% downside risk from its current price of $177.26.
Fair Value
-
According to the consensus of 9 analysts, Teleflex has 34.65% upside to fair value with a price target of $238.68 per share.
TFX vs. S&P 500
-
Over the past 5 trading days, Teleflex has underperformed the S&P 500 by -3.42% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Teleflex does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Teleflex has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Teleflex reported revenues of $764.4M.
Earnings Growth
-
Teleflex earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Teleflex reported earnings per share of $2.36.
Enterprise value:
9.7B
EV / Invested capital:
1.56x
Price / LTM sales:
2.77x
EV / EBIT:
27.62x
EV / Revenue:
3.22x
PEG ratio (5yr expected):
--
EV / Free cash flow:
21.66x
Price / Operating cash flow:
18.62x
Enterprise value / EBITDA:
15.72x
Gross Profit (TTM):
$1.7B
Return On Assets:
3.17%
Net Income Margin (TTM):
7.85%
Return On Equity:
5.32%
Return On Invested Capital:
3.78%
Operating Margin:
18.86%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $2.8B | $3B | $3B | $746.4M | $764.4M | |
| Gross Profit | $1.5B | $1.6B | $1.7B | $416.3M | $430.2M | |
| Operating Income | $523.9M | $573.7M | $401.7M | $165.5M | $144.2M | |
| EBITDA | $756.7M | $799.3M | $619.9M | $230.4M | $220.2M | |
| Diluted EPS | $8.72 | $8.53 | $5.03 | $2.90 | $2.36 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.4B | $1.5B | $1.5B | $2.1B | $1.5B | |
| Total Assets | $6.6B | $7B | $6.8B | $7.5B | $7.5B | |
| Current Liabilities | $475.2M | $562.2M | $610.9M | $585.4M | $618.8M | |
| Total Liabilities | $3.4B | $3.4B | $2.9B | $3.2B | $3B | |
| Total Equity | $3.2B | $3.7B | $3.9B | $4.3B | $4.5B | |
| Total Debt | $2.1B | $2B | $1.7B | $2B | $1.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $445.4M | $470M | $572.1M | $201.6M | $231M | |
| Cash From Investing | -$68.2M | -$258.4M | -$639.8M | -$28.5M | -$21.2M | |
| Cash From Financing | -$415.8M | $258.9M | -$540.3M | $462M | -$174.8M | |
| Free Cash Flow | $373.2M | $379.7M | $450M | $177.2M | $209.8M | |
TFX
Sector
Market Cap
$8.2B
$46.1M
Price % of 52-Week High
69.01%
46.02%
Dividend Yield
0.77%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
-29.36%
-30.52%
Beta (5-Year)
1.156
0.772
Dividend yield:
0.77%
Annualized payout:
$1.36
Payout ratio:
26.86%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$177.10
200-day SMA
Sell
Level
$217.15
Bollinger Bands (100)
Sell
Level
195.55 - 245.49
Chaikin Money Flow
Buy
Level
102M
20-day SMA
Sell
Level
$183.70
Relative Strength Index (RSI14)
Sell
Level
33.97
ADX Line
Buy
Level
18.51
Williams %R
Neutral
Level
-67.5786
50-day SMA
Sell
Level
$201.03
MACD (12, 26)
Sell
Level
-6.68
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Neutral
Level
57M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.79)
Buy
CA Score
(Annual)
Level (0.411)
Buy
Beneish M-Score
(Annual)
Level (-2.4871)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-1.3153)
Buy
Piotroski F Score
(Annual)
Level (7)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Stock Forecast FAQ
In the current month, TFX has received 0 Buy ratings 9 Hold ratings, and 0 Sell ratings. The TFX average analyst price target in the past 3 months is $238.68.
-
Where Will Teleflex Stock Be In 1 Year?
According to analysts, the consensus estimate is that Teleflex share price will rise to $238.68 per share over the next 12 months.
-
What Do Analysts Say About Teleflex?
Analysts are divided on their view about Teleflex share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Teleflex is a Sell and believe this share price will drop from its current level to $200.00.
-
What Is Teleflex's Price Target?
The price target for Teleflex over the next 1-year time period is forecast to be $238.68 according to 9 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 9 analysts rate the stock a Hold.
-
Is TFX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Teleflex is a Hold. 9 of 9 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of TFX?
You can purchase shares of Teleflex via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Teleflex shares.
-
What Is The Teleflex Share Price Today?
Teleflex was last trading at $177.05 per share. This represents the most recent stock quote for Teleflex. Yesterday, Teleflex closed at $177.26 per share.
-
How To Buy Teleflex Stock Online?
In order to purchase Teleflex stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
